Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
16.27
-0.35 (-2.11%)
At close: Feb 21, 2025, 4:00 PM
16.50
+0.23 (1.41%)
After-hours: Feb 21, 2025, 7:01 PM EST
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.29 billion as of February 21, 2025. Its market cap has increased by 32.55% in one year.
Market Cap
1.29B
Enterprise Value
558.82M
1-Year Change
32.55%
Ranking
Category
Stock Price
$16.27
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.29B, an increase of 3,614.10%. That is a compound annual growth rate of 40.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.29B | -15.13% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.33B |
| UnitedHealth Group | 464.92B |
| Johnson & Johnson | 384.68B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.96B |
| Abbott Laboratories | 230.58B |
| AstraZeneca | 228.16B |
| Merck & Co. | 220.08B |